News
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
CVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...
The FDA says semaglutide is no longer in shortage. Local pharmacies aren't sure that's a good thing.
"I don't know any small independent pharmacies that are able to dispense [Ozempic or Wegovy] at high volumes," Hart said. "Most of them are going to find ways to get their patients to go to Walgreens ...
The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...
More than 50 insurers have pledged to streamline and simplify the prior authorization process through six new commitments.
NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans. PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but ...
Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant ...
The health sector makes headlines with global reactions to bird flu impacting chicken exports and the ongoing narrative of ...
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
The nation’s major health insurers are promising to scale back and improve a widely despised practice that leads to care ...
KTLA-TV Los Angeles on MSN4d
CVS policy shift may hike cost of popular GLP-1 medsApproximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results